Erectile dysfunction: anatomical parameters, etiology, diagnosis, and therapy (Q36069701)

12 August 2017

1 reference

title

Erectile dysfunction: anatomical parameters, etiology, diagnosis, and therapy (English)

1 reference

12 August 2017

1 reference

Hafez ES

1

1 reference

12 August 2017

Hafez SD

series ordinal

2

1 reference

12 August 2017

publication date

1 January 2005

1 reference

Systems Biology in Reproductive Medicine

12 August 2017

published in

1 reference

12 August 2017

volume

51

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

15-31

1 reference

Colour Doppler and duplex ultrasound assessment of Peyronie's disease in impotent men.

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1485010490475147

Sildenafil citrate for the treatment of erectile dysfunction in men with Type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1485010490475147

Role of nitric oxide in the physiology of erection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1485010490475147

The efficacy of sildenafil citrate (Viagra) in clinical populations: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1485010490475147

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1485010490475147

Key issues from the clinical trials of apomorphine SL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1485010490475147

Impotence after radical pelvic surgery: physiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1485010490475147

The prevalence and influence of significant psychiatric abnormalities in men undergoing comprehensive management of organic erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1485010490475147

The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1485010490475147

Achieving treatment optimization with sildenafil citrate (Viagra) in patients with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1485010490475147

Efficacy of apomorphine SL in erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1485010490475147

Side-effect profile of sildenafil citrate (Viagra) in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1485010490475147

Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1485010490475147

A 4-year update on the safety of sildenafil citrate (Viagra).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1485010490475147

Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1485010490475147

On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1485010490475147

Minimal time to successful intercourse after sildenafil citrate: results of a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1485010490475147

Long-term effect of sildenafil citrate on erectile dysfunction after radical prostatectomy: 3-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1485010490475147

Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1485010490475147

Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1485010490475147

The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1485010490475147

Effects of tadalafil on erectile dysfunction in men with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1485010490475147

The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1485010490475147

Assessment of the efficacy and safety of Viagra (sildenafil citrate) in men with erectile dysfunction during long-term treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1485010490475147

Sildenafil citrate for treatment of erectile dysfunction in men with type 1 diabetes: results of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1485010490475147

Cross-cultural development of a quality of life measure for men with erection difficulties

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1485010490475147

21 January 2018

Identifiers

DOI

10.1080/1485010490475147

1 reference

12 August 2017

1 reference